Effects of Danhong Injection (丹红注射液) on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention:A Pilot Randomized Study

被引:0
|
作者
XING Wenlong [1 ]
WU Yongjian [2 ]
LIU Hongxu [1 ]
LIU Qingrong [2 ]
ZHOU Qi [1 ]
LI Aiyong [1 ]
ZHANG Zhuhua [1 ]
LI Xuan [1 ]
机构
[1] Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
[2] Department of Cardiology, Fuwai
关键词
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
摘要
Objective: To evaluate the effect of Danhong Injection(丹红注射液, DH) on the index of microcirculatory resistance(IMR) and myocardial injury in patients with unstable angina undergoing elective percutaneous coronary intervention(PCI). Methods: Seventy-eight patients with unstable angina were randomly divided into DH group(39 cases) and the control group(39 cases) during elective PCI. Randomization was performed using a random-number table. The DH group received DH at a dosage of 40 m L(mixed with 250 m L saline, covered by a light-proof bag, intravenous drip) during PCI and daily for 7 consecutive days, while the control group only received the same dosage of saline. Both groups received standardized treatment. The IMR and fractional flow reserve(FFR) were measured at maximal hyperemia before and after PCI. Myocardial markers, including myoglobin, creatine kinase(CK), creatine kinase MB(CK-MB), and coronary troponin T(c Tn T)values were measured at baseline and 24 h after PCI. Results: Among the 78 patients enrolled, the baseline and procedural characteristics were similar between the two groups. There was no significant difference in pre-PCI myocardial markers and coronary physiological indexes between the two groups. However, post-PCI CK and CK-MB levels in the DH group were significantly lower than those in the control group(111.97±80.97 vs.165.47±102.99, P=0.013; 13.08±6.90 vs. 19.75±15.49, P=0.016). Post-PCI myoglobin and c TNT-positive tend to be lower in the DH group than in the control group but did not reach statistical significance(88.07±52.36 vs.108.13±90.94, P=0.52; 2.56% vs.7.69%, P=0.065). Compared with the control group, the post-IMR levels of the DH group tended to decrease, but there was no statistical difference(20.73±13.15 vs. 26.37±12.31, P=0.05).There were no statistical differences in post-FFR in both groups. The peri-procedural myocardial injury of the DH group was significantly lower than that of the control group(2.56% vs. 15.38%, P=0.025). During the 30-d follow-up period, no major adverse cardiovascular events occurred in either group. Conclusion: This study demonstrated benefit of DH in reducing myocardial injury and potential preserving microvascular function in patients with unstable angina undergoing elective PCI.
引用
收藏
页码:846 / 853
页数:8
相关论文
共 21 条
  • [1] Protective effect of Danhong injection in patients with acute myocardial infarction at a high risk of no-reflow during primary percutaneous coronary intervention[J]. Qi YOU,Jing WANG,Wei DONG,Feng TIAN,Hong-Xu LIU,Jing JING,Yun-Dai CHEN.Journal of Geriatric Cardiology. 2019 (05)
  • [2] A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Targeting Inflammation[J]. LI Si-ming,LI Jin-gen,XU Hao.Chinese Journal of Integrative Medicine. 2019(01)
  • [3] 丹红注射液对不稳定型心绞痛血瘀证病人择期PCI围术期心肌损伤的保护作用研究
    谢皛
    张大炜
    刘红旭
    董静
    陈韵岱
    张竹华
    田伟
    李腾飞
    邢文龙
    李爱勇
    [J]. 中西医结合心脑血管病杂志, 2016, 14 (11) : 1185 - 1188
  • [4] 经皮冠状动脉介入治疗(PCI)围手术期心肌损伤中医诊疗专家共识解读
    刘红旭
    [J]. 世界中医药, 2016, 11 (03) : 377 - 380
  • [5] Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention[J] . Fabio Mangiacapra,Edoardo Bressi,Giuseppe Di Gioia,Mariano Pellicano,Luigi Di Serafino,Aaron J. Peace,Jozef Bartunek,Carmine Morisco,William Wijns,Bernard De Bruyne,Emanuele Barbato.International Journal of Cardiology . 2020 (prep)
  • [6] Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway[J] . Si-Nai Li,Ping Li,Wei-Hong Liu,Ju-Ju Shang,Sheng-Lei Qiu,Ming-Xue Zhou,Hong-Xu Liu.Biomedicine & Pharmacotherapy . 2019 (C)
  • [7] Coronary microembolization and microvascular dysfunction[J] . Gerd Heusch,Andreas Skyschally,Petra Kleinbongard.International Journal of Cardiology . 2018
  • [8] Coordinated Activation of VEGF/VEGFR-2 and PPARd Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice
    He, Shuang
    Zhao, Tiechan
    Guo, Hao
    Meng, Yanzhi
    Qin, Gangjian
    Goukassian, David A.
    Han, Jihong
    Gao, Xuimei
    Zhu, Yan
    [J]. PLOS ONE, 2016, 11 (12):
  • [9] Microvascular (Dys) Function and Clinical Outcome in Stable Coronary Disease
    De Bruyne, Bernard
    Oldroyd, Keith G.
    Pijls, Nico H. J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (10) : 1170 - 1172
  • [10] Relation Between Neutrophil-to-Lymphocyte Ratio and Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Lee, Man-Jong
    Park, Sang-Don
    Kwon, Sung Woo
    Woo, Seong-Ill
    Lee, Myung-Dong
    Shin, Sung-Hee
    Kim, Dae-Hyeok
    Kwan, Jun
    Park, Keum-Soo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (09): : 1323 - 1328